Enter your email address to receive promotions, discounts and to be the first to hear about hot sales and other Cymit events!
Applications TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist (1,2). TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels with a low risk of hypoglycemia.
References (1) Arak, T., et al.: Diabetes. Obesity. Metabolism., 14, 271 (2012) (2) Burant, C.F.,et al.: Lancet., 379, 1403 (2012)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.